Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation

References

• NguyenTNHilmerSNCummingRGReview of epidemiology and management of atrial fibrillation in developing countriesInt J Cardiol20131672412242023453870
   PubMed Web of Science ®Google Scholar
• GladstoneDJBuiEFangJPotentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anti-coagulatedStroke20094023524018757287
   PubMed Web of Science ®Google Scholar
• SkanesACHealeyJSCairnsJAFocused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm controlCan J Cardiol20122812513622433576
   PubMed Web of Science ®Google Scholar
• CammAJLipGYDe CaterinaR2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillationEur Heart J2012332719274722922413
   PubMed Web of Science ®Google Scholar
• FurieKLGoldsteinLBAlbersGWOral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke AssociationStroke2012433442345322858728
   PubMed Web of Science ®Google Scholar
• ACTIVE Writing GroupClopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialLancet20063671903191216765759
   PubMed Web of Science ®Google Scholar
• WorthingtonJMGattellariMDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med20093612672267520050383
   PubMed Web of Science ®Google Scholar
• PatelMRMahaffeyKWGargJRivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med201136588389121830957
   PubMed Web of Science ®Google Scholar
• ConnollySJEikelboomJJoynerCApixaban in patients with atrial fibrillationN Engl J Med201136480681721309657
   PubMed Web of Science ®Google Scholar
• LuGAdesAECombination of direct and indirect evidence in mixed treatment comparisonsStat Med2004233105312415449338
   PubMed Web of Science ®Google Scholar
• JansenJPCrawfordBBergmanGStamWBayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisonsValue Health20081195696418489499
   PubMed Web of Science ®Google Scholar
• HigginsJGreenSCochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0LondonCochrane Collaboration2011
   Google Scholar
• WongSLWilczynskiNHaynesRDeveloping optimal search strategies for detecting clinically sound treatment studies in EmbaseJ Med Libr Assoc200694414716404468
   PubMed Web of Science ®Google Scholar
• HigginsJPAltmanDGGøtzschePCThe Cochrane Collaboration’s tool for assessing risk of bias in randomised trialsBMJ2011343d592822008217
   PubMed Web of Science ®Google Scholar
• CooperNJSuttonAJLuGKhuntiKMixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillationArch Intern Med20061661269127516801509
   PubMed Web of Science ®Google Scholar
• SalantiGAdesAEIoannidisJPGraphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorialJ Clin Epidemiol20116416317120688472
   PubMed Web of Science ®Google Scholar
• VerheugtFWho is ineligible for warfarin in atrial fibrillation?Lancet200937451051119683630
   PubMed Web of Science ®Google Scholar
• ACTIVE InvestigatorsEffect of clopidogrel added to aspirin in patients with atrial fibrillationN Engl J Med20093602066207819336502
   PubMed Web of Science ®Google Scholar
• PetersenPBoysenGGodtfredsenJAndersenEDAndersenBPlacebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillationLancet198911751792563096
   PubMed Web of Science ®Google Scholar
• GulløvALKoefoedBGPetersenPFixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillationArch Intern Med1998158151315219679792
   PubMed Web of Science ®Google Scholar
• GulløvALKoefoedBGPetersenPBleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 studyArch Intern Med19991591322132810386508
   PubMed Web of Science ®Google Scholar
• GrangerCBAlexanderJHMcMurrayJJApixaban versus warfarin in patients with atrial fibrillationNew Engl J Med201136598199221870978
   PubMed Web of Science ®Google Scholar
• MantJHobbsFDFletcherKWarfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged study, BAFTA): a randomised controlled trialLancet200737049350317693178
   PubMed Web of Science ®Google Scholar
• ConnollySJLaupacisAGentMRobertsRSCairnsJAJoynerCCanadian Atrial Fibrillation Anticoagulation (CAFA) studyJ Am Coll Cardiol1991183493551856403
   PubMed Web of Science ®Google Scholar
• No authors listedSecondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeLancet1993342125512627901582
   PubMed Web of Science ®Google Scholar
• GiuglianoRPRuffCTBraunwaldEEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med20133692093210424251359
   PubMed Web of Science ®Google Scholar
• SatoHIshikawaKKitabatakeALow-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke TrialStroke20063744745116385088
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSReillyPAWallentinLNewly identified events in the RE-LY trialNew Engl J Med20103631875187621047252
   PubMed Web of Science ®Google Scholar
• Boehringer IngelheimAdvisory committee briefing document: dabigatran etexilate2010 Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM226009.pdfAccessed May 9, 2016
   Google Scholar
• Johnson & JohnsonAdvisory committee briefing document: rivaroxaban for the prevention of stroke and non-central nervous system (CNS) systemic embolism in patients with atrial fibrillation2011 Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM270797.pdfAccessed May 9, 2016
   Google Scholar
• No authors listedStroke Prevention in Atrial Fibrillation Study: final resultsCirculation1991845275391860198
   PubMed Web of Science ®Google Scholar
• RashADownesTPortnerRYeoWWMorganNChannerKSA randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)Age Ageing20073615115617175564
   PubMed Web of Science ®Google Scholar
• PosadaISBarrialesVAlternate-day dosing of aspirin in atrial fibrillationAm Heart J199913813714310385777
   PubMed Web of Science ®Google Scholar
• HicksTStewartFEisingaANOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysisOpen Heart20163e00027926848392
   PubMed Web of Science ®Google Scholar
• CameronCCoyleDRichterTSystematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillationBMJ Open20144e004301
   PubMed Web of Science ®Google Scholar
• AssiriAAl-MajzoubOKanaanAODonovanJLSilvaMMixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillationClin Ther20133596798423870607
   PubMed Web of Science ®Google Scholar
• DogliottiAPaolassoEGiuglianoRPCurrent and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patientsHeart201410039640524009224
   PubMed Web of Science ®Google Scholar
• RoskellNSLipGYNoackHClemensAPlumbJMTreatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilateThromb Haemost20101041106111520967400
   PubMed Web of Science ®Google Scholar
• HarenbergJMarxSDienerHCComparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysisInt Angiol20123133033922801398
   PubMed Web of Science ®Google Scholar
• SchneeweissSGagneJJPatrickARChoudhryNKAvornJComparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillationCirc Cardiovasc Qual Outcomes2012548048622787066
   PubMed Web of Science ®Google Scholar
• LipGYLarsenTBSkjøthFRasmussenLHIndirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillationJ Am Coll Cardiol20126073874622575324
   PubMed Web of Science ®Google Scholar
• RasmussenLHLarsenTBGraungaardTSkjøthFLipGYPrimary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysisBMJ2012345e709723129490
   PubMed Web of Science ®Google Scholar
• TestaLAgnifiliMLatiniRAAdjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillationQJM201210594995722771555
   PubMed Web of Science ®Google Scholar
• BakerWLPhungOJSystematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillationCirc Cardiovasc Qual Outcomes2012571171922912382
   PubMed Web of Science ®Google Scholar
• Biondi-ZoccaiGMalavasiVD’AscenzoFComparative effectiveness of novel oral anticoagulants for atrial fibrillation: evidence from pair-wise and warfarin-controlled network meta-analysesHSR Proc Intensive Care Cardiovasc Anesth20135405423734288
   PubMedGoogle Scholar
• RuffCTGiuglianoRPBraunwaldEComparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsLancet201438395596224315724
   PubMed Web of Science ®Google Scholar
• MorrisonAPolisenaJHusereauDThe effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studiesInt J Technol Assess Health Care201228213814422559755
   PubMed Web of Science ®Google Scholar